Bethkis and Claritin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bethkis (tobramycin) and Claritin (loratadine). Common drug interactions include bronchiectasis among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Bethkis and Claritin. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Bethkis?

Bethkis has active ingredients of tobramycin. eHealthMe is studying from 2,409 Bethkis users. Check the latest studies of Bethkis.

What is Claritin?

Claritin has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 77,316 Claritin users. Check the latest studies of Claritin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

22 people who take Bethkis and Claritin together, and have interactions are studied.

What are the common drug interactions of Bethkis and Claritin, by gender? *:

female:

Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
Pyrexia (fever)
Fatigue (feeling of tiredness)
Acne (skin problems that cause pimples)
Alanine aminotransferase increased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cough
Device dislocation
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)

male:

Death
Dyspnoea (difficult or laboured respiration)
Upper respiratory tract infection
Wheezing (a high-pitched whistling sound made while you breath)
Adverse reaction
Rash papular (redness with papule)
Abdominal pain
Gastric disorder (disease of stomach)
Pneumonia
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)

What are the common drug interactions of Bethkis and Claritin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Asthma
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
Cystic fibrosis (disease of the secretary glands)
Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
Pyrexia (fever)
Rash papular (redness with papule)
Pneumonia
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
Procedural complication
Upper respiratory tract infection

10-19:

Death

20-29:

Cough
Device dislocation
Fatigue (feeling of tiredness)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
Pancreatitis (inflammation of pancreas)
Pyrexia (fever)
Sepsis (a severe blood infection that can lead to organ failure and death)
Adverse reaction
Abdominal pain

30-39:

n/a

40-49:

Dyspnoea (difficult or laboured respiration)
Gastric disorder (disease of stomach)
Weight fluctuation

50-59:

Dyspnoea (difficult or laboured respiration)
Respiratory disorder (respiratory disease)
Wheezing (a high-pitched whistling sound made while you breath)

60+:

n/a

What are the existing conditions these people have? *

Cystic Fibrosis (disease of the secretary glands): 14 people, 63.64%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 5 people, 22.73%
Chronic Respiratory Failure: 4 people, 18.18%
Infective Pulmonary Exacerbation Of Cystic Fibrosis (severe infective lung disease with production of abnormally thick mucus): 3 people, 13.64%
Cystic Fibrosis Lung (fibrosis with cyst in the lung): 3 people, 13.64%
Constipation: 3 people, 13.64%
Asthma: 3 people, 13.64%
Nausea (feeling of having an urge to vomit): 2 people, 9.09%
Hypersensitivity: 2 people, 9.09%
Fungal Infection: 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Bethkis and Claritin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously